Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | mefloquine | 6291 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | mefloquine | 6291 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | mefloquine | 6291 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | mefloquine | 6291 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | mefloquine | 6291 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | mefloquine | 6291 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | pirenperone | 2227 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | pirenperone | 2227 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | pirenperone | 2227 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | pirenperone | 2227 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | pirenperone | 2227 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | pirenperone | 2227 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | pirenperone | 2227 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | sodium phenylbutyrate | 1203 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | sodium phenylbutyrate | 1203 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | sodium phenylbutyrate | 1203 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | sodium phenylbutyrate | 1203 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | sodium phenylbutyrate | 1203 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sodium phenylbutyrate | 1203 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | sodium phenylbutyrate | 1203 | drug-path |